Drugs & Pharmacology Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Pharmacology of Mupirocin in Nasal Application in Healthy Volunteers: Monocentric Study
Conditions: Healthy; Staphylococcus Aureus Infection Interventions: Drug: Mupirocin (50 mg); Drug: Mupirocin (500 mg); Biological: blood samples after Single dose part; Diagnostic Test: nasal swab after Single dose part; Other: Collection of urine after Single dose part; Diagnostic Test: nasal swab during Repeated dose part; Other: Collection of urine during Repeated dose part; Other: nasal swab after Repeated dose part Sponsors: Centre Hospitalier Universitaire de Saint Etienne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 16, 2024 Category: Research Source Type: clinical trials
Network Pharmacology Prediction: Mechanism Study of Puerarin in the Treatment of Giant Cell Tumors of Bone
Conditions: Giant Cell Tumors; Puerarin; Network Pharmacology; Traditional Chinese Medicine; Treatment Interventions: Genetic: gene expression levels Sponsors: Changye Zou Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials
Less Discomfort and Less Pharmacology. Cataract Surgery at Physiologic Intraocular Pressure (IOP)
Conditions: Nuclear Cataract Interventions: Other: High Intraocular Pressure (IOP); Other: Low Intraocular Pressure (IOP) Sponsors: Matthew Rauen Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Pharmacology and Non-pharmacology Approaches in Reducing Children's Pain and Fear During Painful Procedures
Conditions: Pain Interventions: Drug: TICK-B and TkTx-Cream will be combined Sponsors: Uppsala University Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 22, 2024 Category: Research Source Type: clinical trials
Pharmacogenetic Panel to Prevent Adverse Drug Reactions in Daily Primary Care Practice:
Conditions: Pharmacogenomic Drug Interaction; Side Effect of Drug; Ineffective Drug Action; Drug Metabolism, Poor, CYP2D6-Related; Drug Metabolism, Poor, CYP2C19-Related Interventions: Diagnostic Test: PGx panel test Sponsors: Mayo Clinic Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 21, 2024 Category: Research Source Type: clinical trials
Vitamin D Levels in Non-immediate Drug Hypersensitivity Case-control Study
Conditions: Stevens-Johnson Syndrome; Drug Reaction With Eosinophilia and Systemic Symptom; Maculopapular Exanthem; Vitamin D Deficiency; Drug-Induced Rash Sponsors: Chulalongkorn University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials
A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALS
Conditions: Amyotrophic Lateral Sclerosis Interventions: Drug: Darifenacin 7.5 MG Extended Release Oral Tablet; Drug: Placebo Sponsors: McGill University; Universit é de Montréal Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials
The Texas Interprofessional Pharmacogenomics (IPGx)
Conditions: Adverse Drug Reaction Sponsors: Texas A&M University; InnovativeGx; Texas A&M Health Family Care Clinic; iC42 Clinical Research and Development; Goldblatt systems Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 23, 2024 Category: Research Source Type: clinical trials
The Mass Balance Study of LP-168 in Healthy Subjects
Conditions: Clinical Pharmacology Interventions: Drug: [14C]LP-168 Sponsors: Guangzhou Lupeng Pharmaceutical Company LTD. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study to Compare Metformin / Vildagliptin (850 mg/50 mg) Versus Galvumet ®
Conditions: Fed Conditions Interventions: Drug: Metformin / Vildagliptin Film Coated Tablets (850 mg / 50 mg); Drug: Galvumet ® Film Coated Tablets (850 mg / 50 mg) Sponsors: Reseach Laboratory of Clinical and Experimental Pharmacology; Soci été Arabe des Industries Pharmaceutiques SAIPH - Tunisia; Centre National Chalbi Belkahia de Pharmacovigilance CNPV - Tunisia Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2023 Category: Research Source Type: clinical trials
Bioequivalence Study to Compare Metformin / Vildagliptin Versus Galvumet ®
Conditions: Fed Conditions Interventions: Drug: Metformin / Vildagliptin Film Coated Tablets (1000 mg / 50 mg) Sponsors: Reseach Laboratory of Clinical and Experimental Pharmacology; La Soci été Arabe des Industries Pharmaceutiques-Tunisie; Centre National Chalbi Belkahia de Pharmacovigilance-Tunisie Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Population Pharmacokinetic Study Based on Quantitative Pharmacology in Patients With Lenalidomide
Conditions: Multiple Myeloma; Myelodysplastic Syndromes; Lymphoma Sponsors: Qianfoshan Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 5, 2023 Category: Research Source Type: clinical trials
Behavioral Pharmacology of Cannabis in Older Adults
Condition: Health Services for the Aged Intervention: Drug: Cannabis (up to three doses) Sponsor: University of Arkansas Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2023 Category: Research Source Type: clinical trials